Status:
COMPLETED
Regulation of the Release of Inflammatory Mediators From Lung Macrophages.
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Novartis
Boehringer Ingelheim
Conditions:
COPD
Chronic Bronchitis
Eligibility:
All Genders
21-75 years
Brief Summary
The aim of this study is to investigate the mechanisms whereby specific white cells called macrophages found in the lung release inflammatory mediators or chemicals together with enzymes that destroy ...
Detailed Description
Chronic obstructive pulmonary disease (COPD) is the fifth leading cause of death in the UK and is the only common cause of death that is increasing. COPD is currently 6th in the global impact of disea...
Eligibility Criteria
Inclusion
- \- All subjects undergoing surgical resection of the lung
Exclusion
- \- Anyone unable to understand the consent form
Key Trial Info
Start Date :
June 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00147017
Start Date
June 1 2001
End Date
December 1 2010
Last Update
December 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton Hospital/NHLI Imperial College London
London, United Kingdom, SW3 6LY